BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6373861)

  • 21. Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation.
    Krüger GR; Berard CW; DeLellis RA; Graw RG; Yankee RA; Leventhal BG; Rogentine GN; Herzig GP; Halterman RH; Henderson ES
    Am J Pathol; 1971 May; 63(2):179-202. PubMed ID: 4397431
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia.
    Ashida T; Kawanishi K; Ariyama T; Hamasaki H; Maeda Y; Tsubaki K; Kanamaru A
    Int J Hematol; 2000 Jun; 71(4):385-8. PubMed ID: 10905060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation].
    Kreisel W; Fauser AA; Dölken G; Herbst EW
    Z Gastroenterol; 1991 Jun; 29(6):289-93. PubMed ID: 1926962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.
    Goldman JM; Gale RP; Horowitz MM; Biggs JC; Champlin RE; Gluckman E; Hoffmann RG; Jacobsen SJ; Marmont AM; McGlave PB
    Ann Intern Med; 1988 Jun; 108(6):806-14. PubMed ID: 3285744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
    Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophilic folliculitis in a patient after allogeneic bone marrow transplantation: case report and review of the literature.
    Ota M; Shimizu T; Hashino S; Shimizu H
    Am J Hematol; 2004 Jul; 76(3):295-6. PubMed ID: 15224372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease: analogy with scleroderma.
    Bos G; Majoor G; Slaaf D; Reneman R; van Breda Vriesman P
    J Rheumatol; 1988 Sep; 15(9):1339-45. PubMed ID: 3058970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
    Kim RY; Anderlini P; Naderi AA; Rivera P; Ahmadi MA; Esmaeli B
    Am J Ophthalmol; 2002 Jun; 133(6):843-5. PubMed ID: 12036687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abundant macrophage growth in culture from patients with chronic myelogenous leukemia: a risk factor for graft-versus-host disease after bone marrow transplantation.
    Nissen C; Gratwohl A; Tichelli A; Speck B
    Experientia; 1988 Feb; 44(2):167-9. PubMed ID: 3278922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
    Kolb HJ; Socié G; Duell T; Van Lint MT; Tichelli A; Apperley JF; Nekolla E; Ljungman P; Jacobsen N; van Weel M; Wick R; Weiss M; Prentice HG
    Ann Intern Med; 1999 Nov; 131(10):738-44. PubMed ID: 10577296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.
    van der Straaten HM; Fijnheer R; Dekker AW; Nieuwenhuis HK; Verdonck LF
    Br J Haematol; 2001 Jul; 114(1):31-5. PubMed ID: 11472341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of soluble ICAM-1 in serum of patients with acute myeloid leukemia undergoing bone marrow transplantation.
    Maeda Y; Chihara J; Horiuchi F; Miyatake J; Tatsumi Y; Urase F; Irimajiri K; Nakajima S; Horiuchi A
    Am J Hematol; 1996 Jul; 52(3):227-8. PubMed ID: 8756095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic cutaneous graft-versus-host disease in man.
    Shulman HM; Sale GE; Lerner KG; Barker EA; Weiden PL; Sullivan K; Gallucci B; Thomas ED; Storb R
    Am J Pathol; 1978 Jun; 91(3):545-70. PubMed ID: 26221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
    Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
    Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
    Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular manifestations of acute graft versus host disease after allogeneic bone marrow transplant.
    Colón-Acevedo B; Rivera-Román L; Candelario N; Sánchez J
    Bol Asoc Med P R; 2014; 106(2):30-2. PubMed ID: 25065048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRAFT-VERSUS-HOST DISEASE PANUVEITIS AND BILATERAL SEROUS DETACHMENTS: MULTIMODAL IMAGING ANALYSIS.
    Jung JJ; Chen MH; Rofagha S; Lee SS
    Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S54-S61. PubMed ID: 27571426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects and therapy of hemangioma].
    Staindl O
    HNO; 1988 Jul; 36(7):259-66. PubMed ID: 3209425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
    Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich EJ; Andersson BS; O'Brien S; Andreeff M; Fisher H; Cork A
    N Engl J Med; 1993 Sep; 329(11):757-61. PubMed ID: 7688862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.